Data Pipeline

The processes, governance, policies, and technology used to ensure that an organisation's critical shared data entities — such as customers, products, suppliers, and accounts — are accurate, consistent, and controlled across all systems and business units. MDM creates a single trusted source of master data, reducing duplication, resolving conflicts, and enabling reliable reporting and analytics.

The dataset used to train a machine learning model, comprising examples from which the model learns patterns, relationships, and decision boundaries. High-quality, proprietary training data is a significant competitive advantage and intangible asset, particularly in regulated industries where data scarcity creates barriers to entry.

A quantitative measure of data fitness for its intended use, typically assessed across dimensions including accuracy, completeness, consistency, timeliness, uniqueness, and validity. Data quality scores enable organisations to monitor and improve the reliability of their data assets, prioritise remediation efforts, and establish trust in analytical outputs.

Artificially generated data that mimics the statistical properties of real-world datasets, used to train machine learning models when actual data is scarce, sensitive, or expensive to obtain. Synthetic data enables AI development in privacy-constrained domains such as healthcare and finance, while reducing data acquisition costs and regulatory exposure.

Proprietary datasets, analytics capabilities, and data infrastructure that provide competitive advantage. Data assets include customer behavioural data, market intelligence, training datasets for AI models, and proprietary databases that improve decision-making or product quality.

The framework of policies, standards, and processes that ensures data assets are managed consistently, securely, and in compliance with regulations throughout their lifecycle. Strong data governance increases the reliability and value of data as an intangible asset, directly supporting analytics, AI applications, and data monetisation strategies.

The portfolio of drug candidates at various stages of research, development, and regulatory approval within a pharmaceutical or biotechnology company. The pharma pipeline is a critical intangible asset, with each compound's value dependent on its probability of regulatory approval, expected market size, patent protection remaining, and development costs to completion.

Data collected directly by an organisation from its own customers, users, or audience through owned channels such as websites, apps, CRM systems, transactions, and surveys. First-party data is considered the most valuable data category because it is collected with consent, is unique to the organisation, and provides direct insight into customer behaviour and preferences.